Pfizer/BioNTech: BNT162b2s01
Vaccine Type: RNA
This vaccine may also be referred to as BNT162b2SA
Vaccine Trial & Approval Tracker
-
Phase 1
-
Phase 2
-
Phase 3
-
Approved
This vaccine has reached Phase 3 trials.
About Trial Phases
Phase 1:
0
Trials
There are no trials for this phase.
Approvals
This vaccine is not yet approved.
Registered Trials
-
NCT04368728, EUCTR2020-002641-42
Phase 2/3
Argentina, Brazil, Germany, South Africa, Turkey, United States of America
Total Enrollment: 43,998
Official Trial Registration:
-
NCT04949490
Phase 2
Germany
Total Enrollment: 549
Official Trial Registration:
